Search research articles
Contact Us
Filters
Showing results (181-190 of 256) with videos related to
Page
of 26
Sort By:
Molecular Therapy. Methods & Clinical Development
|
September 13, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells
Guido J J Kierkels, Eline van Diest, Patricia Hernández-López, et al.
Bone Marrow Transplantation
|
June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT
J R Passweg, M Labopin, J Cornelissen, et al.
Frontiers in Immunology
|
May 10, 2019
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations
Kirsten Geneugelijk, Kirsten A Thus, Hanneke W M van Deutekom, et al.
Bone Marrow Transplantation
|
March 16, 2025
Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT
A H G Stuut, C Nijssen, L van der Wagen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study
M Schuler, R Herrmann, J L De Greve, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia
Roni Shouval, Annalisa Ruggeri, Myriam Labopin, et al.
The Lancet. Haematology
|
September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis
Roni Shouval, Joshua A Fein, Myriam Labopin, et al.
Hemasphere
|
December 12, 2024
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial
Annoek E C Broers, Ellen Meijer, Bronno van der Holt, et al.
The Lancet. Infectious Diseases
|
April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study
Annalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
Clinical Pharmacology and Therapeutics
|
June 23, 2025
Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
Rashudy F Mahomedradja, Tim Bognàr, Kaj E van Schie, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 256) with videos related to
Sort By:
Page
of 26
Molecular Therapy. Methods & Clinical Development
|
September 13, 2021
Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells
Guido J J Kierkels, Eline van Diest, Patricia Hernández-López, et al.
Bone Marrow Transplantation
|
June 2, 2015
Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT
J R Passweg, M Labopin, J Cornelissen, et al.
Frontiers in Immunology
|
May 10, 2019
Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations
Kirsten Geneugelijk, Kirsten A Thus, Hanneke W M van Deutekom, et al.
Bone Marrow Transplantation
|
March 16, 2025
Improved GVHD-free and relapse-free survival after ex vivo αβTCR and CD19 depleted allogeneic HSCT compared to T cell replete HSCT
A H G Stuut, C Nijssen, L van der Wagen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study
M Schuler, R Herrmann, J L De Greve, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2017
An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia
Roni Shouval, Annalisa Ruggeri, Myriam Labopin, et al.
The Lancet. Haematology
|
September 4, 2019
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis
Roni Shouval, Joshua A Fein, Myriam Labopin, et al.
Hemasphere
|
December 12, 2024
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial
Annoek E C Broers, Ellen Meijer, Bronno van der Holt, et al.
The Lancet. Infectious Diseases
|
April 20, 2026
Maribavir for clinically significant cytomegalovirus infection in haematopoietic cell transplant recipients in Europe: a real-world multicentre retrospective registry study
Annalisa Paviglianiti, Per Ljungman, Rafael de la Camara, et al.
Clinical Pharmacology and Therapeutics
|
June 23, 2025
Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations
Rashudy F Mahomedradja, Tim Bognàr, Kaj E van Schie, et al.
Page
of 26